J. . Simonović Babić, “Real-life data on the efficacy and safety of ombitasvir/paritaprevir/ /ritonavir + dasabuvir + ribavirin in the patients with genotype 1 chronic hepatitis C virus infection in Serbia”, Vojnosanit Pregl, vol. 76, no. 5, Feb. 2021, doi: 10.2298/VSP170727186S.